Senior insider sale
CHIEF FINANCIAL OFFICER at FENNEC PHARMACEUTICALS INC. — senior position signals high conviction
$883.9K
75K shares
What this filing means
ANDRADE ROBERT plans to sell 75K shares of FENNEC PHARMACEUTICALS INC. valued at approximately $883.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/27/2026ACC: 0001950047-26-008768
Officer· CHIEF FINANCIAL OFFICER
Since Feb 2026
75K
Shares to sell
$883.9K
Approx. market value
75K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercised Shares
Cash
8/13/2020
75KTotal acquired75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/13/2020 | Exercised Shares Cash | 75K | — |
| Total | 75K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
75K
Market value
$883.9K
8/27/2026
Total
Units
75K
Value
$883.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/27/2026 | 75K | $883.9K | NASDAQ | Planned |
| Total | 75K | $883.9K | ||